Analyst Ratings February 4, 2026

Morgan Stanley nudges Evercore price target higher to $381 as earnings outlook improves

Analyst lifts 2026-27 EPS estimates and keeps Equalweight rating amid stronger advisory and management revenue projections

By Maya Rios EVR
Morgan Stanley nudges Evercore price target higher to $381 as earnings outlook improves
EVR

Morgan Stanley raised its price target on Evercore Partners to $381 from $376 while retaining an Equalweight rating. The firm increased its 2026 and 2027 EPS forecasts modestly, citing higher projected advisory, underwriting, commission and investment management revenues, offset in part by rising expenses. Evercore recently posted stronger-than-expected fourth-quarter 2025 results and has delivered notable stock returns over the past year.

Key Points

  • Morgan Stanley raised Evercore's price target to $381 from $376 while keeping an Equalweight rating, using a 14.0x P/E multiple on its 2027 EPS estimate.
  • 2026 EPS was increased by $0.38 to $19.75 and 2027 EPS by $0.30 to $27.19, driven by projected increases in advisory, underwriting, commissions and investment management revenue.
  • Evercore reported strong fourth-quarter 2025 results with adjusted EPS of $5.13 and revenue of $1.28 billion, and has delivered 21.22% stock returns over the past year; sectors impacted include investment banking, capital markets and asset management.

Morgan Stanley has increased its target share price for Evercore Partners (NYSE: EVR) to $381.00 from $376.00, while keeping an Equalweight recommendation on the investment banking advisory firm. The change follows modest upward revisions to earnings per share estimates for 2026 and 2027 and leaves Morgan Stanley's valuation approach unchanged.

The brokerage raised its 2026 EPS forecast by $0.38, to $19.75, and lifted its 2027 EPS projection by $0.30, to $27.19. Morgan Stanley applied the same 14.0x price-to-earnings multiple used previously to its slightly higher 2027 EPS figure to arrive at the new $381 target.

According to the firm, the higher forecasts reflect anticipated increases across several revenue streams - advisory fees, underwriting commissions, trading commissions and investment management revenue - even after accounting for higher expense assumptions. Morgan Stanley now models an improvement in Evercore's adjusted compensation ratio from 64.2% in 2025 to 62.8% in 2026 and 61.0% in 2027.

However, the bank notes non-compensation costs are expected to rise more than previously anticipated based on company guidance, with 2026 non-compensation expenses projected to increase by 16-17%. That dynamic tempers margin improvement relative to the compensation-line gains.

Evercore's recent operating performance has supported the analyst revisions. The company delivered robust revenue growth of 27.03% over the last twelve months and reported fourth-quarter 2025 results that beat consensus expectations. Evercore posted adjusted earnings per share of $5.13 for the quarter, ahead of the $4.02 forecast, and reported revenue of $1.28 billion versus $1.12 billion expected.

At the time of Morgan Stanley's update, Evercore shares were trading at $349.57. The stock has returned 21.22% over the prior year, despite exhibiting price volatility consistent with a reported beta of 1.56. The company's market capitalization stands at $13.8 billion.

Valuation metrics noted alongside the update include a PEG ratio of 0.41, per InvestingPro data, which the report characterized as an attractive level relative to projected growth rates.


Summary of the firm-level outlook and modeling assumptions:

  • Price target: raised to $381 from $376 using a 14.0x multiple on 2027 EPS
  • EPS revisions: 2026 EPS increased by $0.38 to $19.75; 2027 EPS increased by $0.30 to $27.19
  • Revenue drivers: expected growth in advisory, underwriting, commissions and investment management revenue
  • Expense outlook: improved adjusted compensation ratio offset by a larger-than-previously-modeled rise in non-compensation expenses (company guidance implies a 16-17% increase in 2026)

The net effect of Morgan Stanley's revisions is a modest increase in the price target while maintaining an Equalweight stance on Evercore's stock. The firm's analysis highlights improving top-line trends and margin gains from compensation efficiency, balanced by higher operating costs.

Risks

  • Higher non-compensation expenses: company guidance implies 2026 non-compensation costs will rise 16-17%, which could slow margin improvement and affect profitability in investment banking and asset management operations.
  • Earnings and valuation sensitivity: the $381 target is based on a 14.0x multiple applied to 2027 EPS; deviations in revenue or expense performance versus Morgan Stanley’s model could change valuation outcomes for the firm's stock.
  • Market volatility: Evercore's reported beta of 1.56 and its recent price volatility introduce uncertainty for investors in financial-sector and capital markets exposures.

More from Analyst Ratings

Coherus Secures Johnson & Johnson Supply Pact for Phase 1b TCE Combination in mCRPC Feb 4, 2026 Leerink Sticks with Outperform on Cencora, Flags Durable Growth Despite Near-Term Revenue Miss Feb 4, 2026 Wolfe Research Keeps Outperform on RTX After Missile Production Framework Deal Feb 4, 2026 Raymond James Lifts Flex Price Target to $80 Citing Data‑center Strength; Nextpower JV Advances Saudi Solar Plans Feb 4, 2026 BTIG Lifts GE HealthCare Price Target to $91 After Q4 Beat; Keeps Buy Rating Feb 4, 2026